Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-5180

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-5180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole-figure-1 (Lansoprazole Figure 1)

The text describes a chart or a graph that shows the mean severity of heartburn by study day for evaluable patients. The severity is measured on a scale of 0 (none) to 3 (severe). There are three treatments options listed: Placebo, Lansoprazole 15 mg, and Lansoprazole 30 mg. The graph shows that the severity of heartburn decreases over time for all treatments, and that both Lansoprazole doses perform better than the placebo. The x-axis shows the study days from the start of the treatment. The text also includes a table with some numbers, but it is not clear what these numbers are referring to.*

FDA Label Image

Lansoprazole-figure-2 (Lansoprazole Figure 2)

FDA Label Image

Lansoprazole-str (Lansoprazole Str)

FDA Label Image

Label Image (Lbl500905180)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.